期刊文献+

肿瘤自身抗体检测对早期肺癌的诊断价值 被引量:6

The value of combined detection of tumor autoantibodies in the diagnosis of early lung cacer
原文传递
导出
摘要 目的探讨肺癌自身抗体P53、PGP9.5、SOX2、GAGE7、GBU4-5、MAGEA1和CAGE对早期肺癌的诊断价值。方法采用ELISA法检测肺癌组(46例首次确诊的肺癌患者)和对照组(包含22名肺部良性疾病患者及23例健康体检者)血清中肺癌自身抗体P53、PGP9.5、SOX2、GAGE7、GBU4-5、MAGEA1和CAGE表达水平,分析评价7种肺癌自身抗体单独检测和联合检测对肺癌的临床诊断价值。结果肺癌组患者血清中7种自身抗体的水平明显高于对照组(均P<0.05)。肺癌组患者7种抗体联合检测的阳性率明显高于对照组(65.22%vs 15.56%,χ^(2)=23.252,P<0.001)。单一肺癌自身抗体检测的敏感性为4.35%~36.96%,特异性为93.30%~100.00%,AUC为0.695~0.832。7种肺癌抗体联合检测的敏感性为65.22%,特异性为84.44%,AUC为0.897。结论早期肺癌患者血清中7种肺癌自身抗体水平均较高。单一肺癌自身抗体检测的特异性较高,但敏感性较低。7种肺癌自身抗体联合检测具有较高的敏感性,可成为临床早期肺癌新的辅助诊断指标。 Objective To explore the value of lung cancer(LC)autoantibodies(P53,PGP9.5,SOX2,GAGE7,GBU4-5,MAGEA1,CAGE)in the diagnosis of early lung cancer.Methods The expressions of seven lung cancer autoantibodies were detected with Enzyme-Linked Immunosorbent Assay(ELISA)in 46 newly diagnosed lung cancer patients(LC Group),22 patients with benign pulmonary disease and 23 healthy individuals(Control Group).The values of single and combined detection of 7 lung cancer autoantibodies were evaluated.Results The levels of the 7 autoantibodies in LC group were significantly higher than in control group(all P<0.05).The positive rate of the 7 autoantibodies in LC group was significantly higher than in control group(65.22%vs 15.56%,χ^(2)=23.252,P<0.001).The sensitivity of single LC autoantibody test was 4.35%to 36.96%;the specificity was 93.30%to 100.00%;and the AUC was 0.695 to 0.832.The sensitivity of combined detection was 65.22%;the specificity was 84.44%and AUC was 0.897.Conclusion The levels of 7 LC autoantibodies in patients with early lung cancer are high.Single LC autoantibody test had high specificity and low sensitivity.The combined detection of 7 LC autoantibodies had high sensitivity,which may become a new auxiliary diagnosis indicators of early lung cancer.
作者 綦霞 孙丽娟 郭连英 孙文平 王玉梅 QI Xia;SUN Li-juan;GUO Lian-ying;SUN Wen-ping;WANG Yu-mei(Laboratory Medicine College,Dalian Medical University,Dalian,Liaoning 116044,China;不详)
出处 《中国微生态学杂志》 CAS CSCD 2021年第3期301-303,308,共4页 Chinese Journal of Microecology
基金 国家自然科学基金(81502776)。
关键词 肺癌 自身抗体 联合检测 早期诊断 Lung cancer Autoantibodies Joint detection Early diagnosis
  • 相关文献

参考文献4

二级参考文献72

  • 1潘振奎,张力,张星,王欣,李宁,徐菲,常建华,管忠震.中国非小细胞肺癌患者表皮生长因子受体突变的研究[J].癌症,2005,24(8):919-923. 被引量:44
  • 2邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:151
  • 3van Noord JA,Aumann JL,Janssens E,et al.Effects of tiotropium with and without formoterol on airflowobstruction and testing hyperinflation in pa-tients with COPD. Chest . 2006
  • 4Stellman SD,Muscat JE,Thompson S,et al.Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer . 1997
  • 5Hsieh RK,Lim KH,Kuo HT,et al.Female sex and bronchio-loalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer. Chest . 2005
  • 6Muller PA, Vousden KH. Mutant PS3 in cancer: new functions and therapeutic opportunities. Cancer Cell, 2014, 25(3): 304-317.
  • 7Kandoth C, McLellan MD, Vandin F, et al. Mutational landscape and significance across 12 major cancer types. Nature, 2013, 502(7471): 333-339.
  • 8Hong B, van den Heuvel AP, Prabhu VV, et al. Targeting tumor suppressor P53 for cancer therapy: strategies, challenges and opportunities. Curr Drug Targets, 2014, 15(1): 80-89.
  • 9Tsao MS, Aviel-Ronen S, Ding K, et al. Prognostic and predictive importance of P53 and RAS for adjuvant chemotherapy in non small- cell lung cancer.J Clin Oncol, 2007, 25(33): 5240-5247.
  • 10Kosaka Tj Yatabe Yj Onozato R, et al. Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol, 2009, 4(1): 22-29.

共引文献262

同被引文献69

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部